Cigarette Smoking Cessation Services in Outpatient Substance Abuse Treatment Programs in the United States

Overview

Journal J Subst Abuse Treat

Specialty Psychiatry

Date 2007 May 19

PMID 17509809

Citations 66

Authors

Peter D Friedmann

Lan Jiang

Kimber P Richter

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of this study was to estimate the prevalence and determinants of cigarette smoking cessation treatment in U.S. outpatient substance abuse treatment (OSAT) units.

Methods: Program directors and clinical supervisors from a national sample of 550 OSAT units in the United States were surveyed in 2004-2005. Supervisors reported the availability of cigarette smoking assessment, and individual or group counseling and pharmacotherapy for smoking cessation. This analysis examines whether institutional and resource factors influence the delivery of these services.

Results: Of OSAT programs in the United States, 41% offer smoking cessation counseling or pharmacotherapy, 38% offer individual/group counseling, and 17% provide quit-smoking medication. In multivariate models, hospital affiliation, service breadth, the priority given to physical health, the availability of medication to treat addictive problems, assessment of cigarette smoking, and a greater perception of the proportion of patients who smoke were associated with the delivery of smoking cessation services. Program size and medical staffing also influenced the availability of quit-smoking medication.

Conclusions: Of U.S. OSAT programs, two in five offer behavioral treatment for smoking cessation, but fewer than one in five provide access to pharmacotherapy. Substance abuse treatment programs that are medically oriented, provide more comprehensive services, and recognize the burden of tobacco smoking among their patients are more likely to deliver evidence-based smoking cessation services.

Citing Articles

Exploring the barriers and facilitators to the uptake of smoking cessation services for people in treatment or recovery from problematic drug or alcohol use: A qualitative systematic review.

Iyahen E, Omoruyi O, Rowa-Dewar N, Dobbie F PLoS One. 2023; 18(7):e0288409.

PMID: 37440505 PMC: 10343091. DOI: 10.1371/journal.pone.0288409.

Behavioral health care provider's beliefs, confidence, and knowledge in treating cigarette smoking in relation to their use of the 5A's intervention.

Jafry M, Martinez J, Chen T, Britton M, Martinez Leal I, Rogova A Addict Behav Rep. 2023; 17:100493.

PMID: 37347047 PMC: 10279772. DOI: 10.1016/j.abrep.2023.100493.

A Widening Divide: Cigarette Smoking Trends Among People With Substance Use Disorder And Criminal Legal Involvement.

Saloner B, Li W, Flores M, Progovac A, Le Cook B Health Aff (Millwood). 2023; 42(2):187-196.

PMID: 36745833 PMC: 10157835. DOI: 10.1377/hlthaff.2022.00901.

Implementation and Outcomes of a Comprehensive Tobacco Free Workplace Program in Opioid Treatment Centers.

Taing M, Nitturi V, Chen T, Kyburz B, Martinez Leal I, Correa-Fernandez V Int J Environ Res Public Health. 2022; 19(1).

PMID: 35010499 PMC: 8744608. DOI: 10.3390/ijerph19010239.

Screening and Treatment of Tobacco Use Disorder in Mental Health Clinics in New York State: Current Status and Potential Next Steps.

Zern A, Seserman M, Dacus H, Wallace B, Friedlander S, Manseau M Community Ment Health J. 2020; 57(6):1023-1031.

PMID: 33083939 DOI: 10.1007/s10597-020-00726-0.

References

Burling T, Burling A, Latini D . A controlled smoking cessation trial for substance-dependent inpatients. J Consult Clin Psychol. 2001; 69(2):295-304. DOI: 10.1037//0022-006x.69.2.295. View

Pollack H, DAunno T, Lamar B . Outpatient substance abuse treatment and HIV prevention: an update. J Subst Abuse Treat. 2005; 30(1):39-47. DOI: 10.1016/j.jsat.2005.09.002. View

. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA. 2000; 283(24):3244-54. View

Lasser K, Boyd J, Woolhandler S, Himmelstein D, McCormick D, Bor D . Smoking and mental illness: A population-based prevalence study. JAMA. 2000; 284(20):2606-10. DOI: 10.1001/jama.284.20.2606. View

Richter K, Gibson C, Ahluwalia J, Schmelzle K . Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health. 2001; 91(2):296-9. PMC: 1446533. DOI: 10.2105/ajph.91.2.296. View

Stitzer M . Combined behavioral and pharmacological treatments for smoking cessation. Nicotine Tob Res. 2002; 1 Suppl 2:S181-7; discussion S207-10. DOI: 10.1080/14622299050012041. View

Richter K, Ahluwalia H, Mosier M, Nazir N, Ahluwalia J . A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002; 97(7):861-9. DOI: 10.1046/j.1360-0443.2002.00162.x. View

Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik M . Smoking cessation in methadone maintenance. Addiction. 2002; 97(10):1317-28; discussion 1325. DOI: 10.1046/j.1360-0443.2002.00221.x. View

Joseph A, Willenbring M, Nelson D, Nugent S . Timing of alcohol and smoking cessation study. Alcohol Clin Exp Res. 2002; 26(12):1945-6. DOI: 10.1097/01.ALC.0000041004.10869.E0. View

10.

Currie S, Nesbitt K, Wood C, Lawson A . Survey of smoking cessation services in Canadian addiction programs. J Subst Abuse Treat. 2003; 24(1):59-65. DOI: 10.1016/s0740-5472(02)00344-6. View

11.

Friedmann P, Lemon S, Durkin E, DAunno T . Trends in comprehensive service availability in outpatient drug abuse treatment. J Subst Abuse Treat. 2003; 24(1):81-8. PMC: 3668548. DOI: 10.1016/s0740-5472(02)00323-9. View

12.

Fagan P, King G, Lawrence D, Petrucci S, Robinson R, Banks D . Eliminating tobacco-related health disparities: directions for future research. Am J Public Health. 2004; 94(2):211-7. PMC: 1448230. DOI: 10.2105/ajph.94.2.211. View

13.

Bien T, Burge R . Smoking and drinking: a review of the literature. Int J Addict. 1990; 25(12):1429-54. DOI: 10.3109/10826089009056229. View

14.

Wheeler J, Fadel H, DAunno T . Ownership and performance of outpatient substance abuse treatment centers. Am J Public Health. 1992; 82(5):711-8. PMC: 1694132. DOI: 10.2105/ajph.82.5.711. View

15.

McCaughrin W, Price R . Effective outpatient drug treatment organizations: program features and selection effects. Int J Addict. 1992; 27(11):1335-58. DOI: 10.3109/10826089209047355. View

16.

Sees K, Clark H . When to begin smoking cessation in substance abusers. J Subst Abuse Treat. 1993; 10(2):189-95. DOI: 10.1016/0740-5472(93)90044-3. View

17.

Orleans C, Hutchinson D . Tailoring nicotine addiction treatments for chemical dependency patients. J Subst Abuse Treat. 1993; 10(2):197-208. DOI: 10.1016/0740-5472(93)90045-4. View

18.

Hser Y, McCarthy W, Anglin M . Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med. 1994; 23(1):61-9. DOI: 10.1006/pmed.1994.1009. View

19.

DAunno T, Vaughn T . An organizational analysis of service patterns in outpatient drug abuse treatment units. J Subst Abuse. 1995; 7(1):27-42. DOI: 10.1016/0899-3289(95)90304-6. View

20.

Hurt R, Offord K, Croghan I, Kottke T, Morse R, Melton 3rd L . Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996; 275(14):1097-103. DOI: 10.1001/jama.275.14.1097. View